RAPT Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

1.79B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	1.53M	-2.29M	-59.95%
Dec 31, 2021	3.81M	-1.23M	-24.38%
Dec 31, 2020	5.04M	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Immunocore Holdings	379.59M
Monte Rosa Therapeutics	181.54M
Agios Pharmaceuticals	44.79M
Precigen	6.31M
Upstream Bio	2.80M
Celldex Therapeutics	2.60M
Oculis Holding AG	992.00K

Revenue Rankings

RAPT News

8 days ago - Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
15 days ago - Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK - GlobeNewsWire
15 days ago - RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition - Invezz
15 days ago - GSK to buy food allergy drug maker RAPT in $2.2bn deal - The Guardian
15 days ago - This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. - Barrons
15 days ago - GSK to buy RAPT Therapeutics for $2.2 billion - Reuters
20 days ago - RAPT Therapeutics, Inc. (RAPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
4 weeks ago - RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire

More News